Naoluo Xintong capsule ameliorates apoptosis induced by endoplasmic reticulum stress in rats with cerebral ischemia/ reperfusion injury
Author(s) -
Sipeng Wu,
Xinxin Piao,
Ning Wang,
Yan Zhai
Publication year - 2020
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 19
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-20-387
Subject(s) - creb , medicine , tunel assay , apoptosis , unfolded protein response , reperfusion injury , ischemia , pharmacology , endoplasmic reticulum , chop , western blot , terminal deoxynucleotidyl transferase , microbiology and biotechnology , biochemistry , biology , immunohistochemistry , lymphoma , gene , transcription factor
Naoluo Xintong (NLXT) capsuleis a newly developed drug recorded in the Chinese Pharmacopoeia. It is derived from traditional Chinese medicine (TCM) NLXT decoction, and has been widely used to treat cerebrovascular diseases in clinic. However, it is currently unknown whether it improve cerebral ischemia reperfusion (I/R) injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom